Chemotherapy-induced Febrile Neutropenia

• CLINICAL_TRIALS trial_result · 2022-02-14
  Clinical Trial Update: Efficacy and Safety Study With MYL-1401H and Neulasta [Phase 3]

  Phase 3 trial update evaluating efficacy and safety of MYL-1401H with Neulasta in breast cancer patients with chemotherapy-induced febrile n…

• CLINICAL_TRIALS trial_result · 2020-03-13
  Clinical Trial Update: Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients [Phase 4]

  Phase 4 trial updating timing of granulocyte colony-stimulating factor (G-CSF) after chemotherapy in pediatric patients to assess outcomes.

• CLINICAL_TRIALS trial_result · 2019-02-11
  Clinical Trial Update: Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia

  Non-interventional study evaluating home administration of the filgrastim biosimilar Nivestim for primary prophylaxis of chemotherapy-induce…